For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Axys Pharmaceuticals, Inc.

USPTO Granted Patents = 40

CIPO Patents = 1

Forward Citations = 399

Loading Chart...

Loading Chart...

108 inventors (with patents filed for the assignee):

James T Palmer (12 out of 19 patents)

Thomas E Jenkins (5 out of 61 patents)

Sukanthini Thurairatnam (5 out of 10 patents)

4. John W Patterson (5 out of 32 patents)

5. David John Aldous (5 out of 11 patents)

6. John O Link (4 out of 99 patents)

7. Michael Graupe (4 out of 75 patents)

8. Cameron Black (4 out of 30 patents)

9. Jacques Yves Gauthier (4 out of 34 patents)

10. Chun Sing Li (4 out of 28 patents)

11. Vouy-Linh Truong (4 out of 5 patents)

12. Michel Therien (4 out of 37 patents)

13. Dan McKay (4 out of 6 patents)

14. Christophe Mellon (4 out of 10 patents)

15. Christopher I Bayly (4 out of 18 patents)

Core Competencies:

Cysteine Protease Inhibitors

Cathepsin Inhibitors

Protease Inhibitors

Sulfonamide Compounds

Benzimidazole Compositions

Urokinase Inhibitors

Gene Targeting

Machine Learning in Biology

Serine Protease Inhibitors

Immunomediated Inflammatory Disorders

Anticoagulants

Asthma Related Genes

40 patents: Sort by Forward Citations

1. 8772336 - Cathepsin cysteine protease inhibitors (2014-07-08),

2. 8318748 - Cathepsin cysteine protease inhibitors (2012-11-27),

3. 7973037 - Cathepsin cysteine protease inhibitors (2011-07-05),

4. 7375134 - Cathepsin cysteine protease inhibitors (2008-05-20),

5. 7226921 - Compounds and compositions as cathepsin S inhibitors (2007-06-05),

6. 7196099 - Compounds and compositions as cathepsin inhibitors (2007-03-27),

7. 7064123 - Compounds and compositions as cathepsin inhibitors (2006-06-20),

8. 7030116 - Compounds and compositions as cathepsin inhibitors (2006-04-18),

9. 7012075 - Cathepsin cysteine protease inhibitors (2006-03-14),

10. 6977256 - Compounds and compositions as cathepsin S inhibitors (2005-12-20),

11. 6900237 - Sulfonamide compounds as protease inhibitors (2005-05-31),

12. 6867200 - (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors (2005-03-15),

13. 6593327 - Compounds and compositions as protease inhibitors (2003-07-15),

14. 6576630 - Compounds and compositions as protease inhibitors (2003-06-10),

15. 6562854 - Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders (2003-05-13),

Axys Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on developing innovative therapies for various diseases. With a strong emphasis on research and development, Axys Pharma is committed to discovering breakthrough treatments and improving patient outcomes. Our team of dedicated scientists and medical professionals works tirelessly to address unmet medical needs and bring life-saving medicines to market. Visit our website to learn more about our pipeline, partnerships, and ongoing clinical trials.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

40 Patents

#38 in South San Francisco, CA

#1,979 in California

#8,351 in US

#16,570 in the World

South San Francisco, CA, United States of America

Axys Pharmaceuticals, Inc.

Forward Citations = 399

108 inventors:

James T Palmer (12 out of 19 patents)

Thomas E Jenkins (5 out of 61 patents)

Sukanthini Thurairatnam (5 out of 10 patents)

4. John W Patterson (5 out of 32 patents)

5. David John Aldous (5 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…